ArticleCurrent medical imaging2025
Diagnostic Value of Dual Energy Technology of Dual Source CT in Differentiation Grade of Colorectal Cancer.
Article in Current medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Electron Density Dual-energy CT for Liver Metastasis Detection Compared with Conventional and Virtual Monoenergetic Images at 40 keV.Current medical imaging · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionColorectal cancer (CRC) is a leading cause of cancer-related morbidity and mortality. Accurate differentiation of tumor grade is crucial for prognosis and treatment planning. This study aimed to evaluate the diagnostic value of dual-source CT dual-energy technology parameters in distinguishing CRC differentiation grades.
methodsA retrospective analysis was conducted on 87 surgically and pathologically confirmed CRC patients (64 with medium-high differentiation and 23 with low differentiation) who underwent dual-source CT dual-energy enhancement scanning. Normalized iodine concentration (NIC), spectral curve slope (K), and dual-energy index (DEI) of the tumor center were measured in arterial and venous phases. Differences in these parameters between differentiation groups were compared, and ROC curve analysis was performed to assess diagnostic efficacy.
resultsThe low-differentiation group exhibited significantly higher NIC, K, and DEI values in both arterial and venous phases compared to the mediumhigh differentiation group (P < 0.01). In the arterial phase, NIC, K, and DEI yielded AUC values of 0.920, 0.770, and 0.903, respectively, with sensitivities of 95.7%, 65.2%, and 91.3%, and specificities of 82.8%, 75.0%, and 75.0%, respectively. In the venous phase, AUC values were 0.874, 0.837, and 0.886, with sensitivities of 91.3%, 82.6%, and 91.3%, and specificities of 68.75%, 75.0%, and 73.4%. NIC in the arterial phase showed statistically superior diagnostic performance compared to K values (P < 0.05). DISCUSSION: Dual-energy CT parameters, particularly NIC in the arterial phase, demonstrate high diagnostic accuracy in differentiating CRC grades. These findings suggest that quantitative dual-energy CT metrics can serve as valuable non-invasive tools for tumor characterization, aiding in clinical decision-making. Study limitations include its retrospective design and relatively small sample size.
conclusionNIC, K, and DEI values in dual-energy CT scans are highly effective in distinguishing CRC differentiation grades, with arterial-phase NIC showing the highest diagnostic performance. These parameters may enhance preoperative assessment and personalized treatment strategies for CRC patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.